Science News
from research organizations

Study provides new evidence on role of person-to person transmission in drug-resistant TB

Date:
January 18, 2017
Source:
Emory Health Sciences
Summary:
A study of extensively drug-resistant tuberculosis (XDR TB)in KwaZulu province, South Africa, builds on a growing body of evidence showing person-to-person transmission, not just inadequate treatment, is driving the spread of XDR TB.
Share:
FULL STORY

A study published in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014. The study was conducted by a team of researchers from Emory University, the U.S. Centers for Disease Control and Prevention, Albert Einstein College of Medicine, and the University of KwaZulu-Natal in South Africa and was funded by the U.S. National Institute of Allergy and Infectious Diseases at the National Institutes of Health. It builds on a growing body of evidence showing that person-to-person transmission, not just inadequate treatment, is driving the spread of drug-resistant TB.

South Africa is experiencing a widespread epidemic of XDR TB, the deadliest form of TB, including a tenfold increase in cases between 2002 and 2015. The study found that the majority of cases (69 percent) in high HIV- and high TB-burden areas happened due to person-to-person transmission rather than inadequate TB treatment in South Africa. By using social networks analysis, the study identified numerous opportunities for transmission not only in hospitals, but also in community settings, such as households and workplaces. The study has important implications for efforts to prevent drug-resistant TB, which have traditionally focused on ensuring that patients receive accurate and complete TB treatment.

"These findings provide insight as to why this epidemic continues despite interventions to improve TB treatment over the past decade. Public health and research efforts must focus more intensely on identifying and implementing additional or new interventions that halt transmission in hospitals and community settings," says Neel R. Gandhi, MD, associate professor of epidemiology at Emory's Rollins School of Public Health.

The study included 404 XDR TB patients in KwaZulu-Natal, South Africa and was led by a team of researchers including Gandhi and Sarita Shah, MD, MPH, of of CDC's Division of Global HIV & TB. Researchers examined the role of transmission by combining robust genotyping methods with social network and epidemiologic analysis. The study is the first of its kind, bringing together these multiple state-of-the-art methods to study XDR TB transmission in a high-incidence setting.

"These findings are further proof that we need to better detect, prevent, diagnose, and treat drug-resistant TB," says CDC Director Tom Frieden, MD, MPH. "TB resistant to last-resort drugs is spreading through hospitals and homes, at work, and in other places in this high burden community. The only way to stop this disease is by improving infection control and rapidly finding and effectively treating people with TB."

What is XDR TB?

Drug-resistant TB is a significant global epidemic. Reported in 105 countries, XDR TB is resistant to at least four of the key anti-TB drugs. In most settings, treatment is effective less than 40 percent of the time, with death rates as high as 80 percent for patients who also have HIV.

Interrupting the spread of TB can be particularly challenging in countries most affected by the disease. In settings with limited resources, measures to prevent the spread of TB such as contact tracing, implementation of effective infection control measures, improved ventilation in hospitals and better training for healthcare workers, can be difficult.

Study authors suggest that breaking the cycle of transmission of drug-resistant TB requires a greater focus on infection control efforts -- while also maintaining global programs to quickly detect and effectively treat all people with TB.


Story Source:

Materials provided by Emory Health Sciences. Note: Content may be edited for style and length.


Journal Reference:

  1. N. Sarita Shah, Sara C. Auld, James C.M. Brust, Barun Mathema, Nazir Ismail, Pravi Moodley, Koleka Mlisana, Salim Allana, Angela Campbell, Thuli Mthiyane, Natashia Morris, Primrose Mpangase, Hermina van der Meulen, Shaheed V. Omar, Tyler S. Brown, Apurva Narechania, Elena Shaskina, Thandi Kapwata, Barry Kreiswirth, Neel R. Gandhi. Transmission of Extensively Drug-Resistant Tuberculosis in South Africa. New England Journal of Medicine, 2017; 376 (3): 243 DOI: 10.1056/NEJMoa1604544

Cite This Page:

Emory Health Sciences. "Study provides new evidence on role of person-to person transmission in drug-resistant TB." ScienceDaily. ScienceDaily, 18 January 2017. <www.sciencedaily.com/releases/2017/01/170118181730.htm>.
Emory Health Sciences. (2017, January 18). Study provides new evidence on role of person-to person transmission in drug-resistant TB. ScienceDaily. Retrieved May 29, 2017 from www.sciencedaily.com/releases/2017/01/170118181730.htm
Emory Health Sciences. "Study provides new evidence on role of person-to person transmission in drug-resistant TB." ScienceDaily. www.sciencedaily.com/releases/2017/01/170118181730.htm (accessed May 29, 2017).

RELATED STORIES